Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Stroke

Stroke outcomes after 90 days—out of sight, out of mind?

Nature Reviews Neurology volume 11, pages 187–188 (2015)Cite this article

Subjects

A recent study has found that one in six people who are independent at 3 months after stroke deteriorate and need assistance by 12 months. Older women with comorbidities, and patients not given appropriate secondary stroke prevention were most at risk. Anticipation and prevention of deterioration could help reduce the later burden of stroke.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Katzan, I. L. et al. Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45, 918–944 (2014).

    Article  Google Scholar 

  2. Ullberg, T., Zia, E., Petersson, J. & Norrving, B. Changes in functional outcome over the first year after stroke: an observational study from the Swedish Stroke Register. Stroke 46, 389–394 (2015).

    Article  Google Scholar 

  3. Ovbiagele, B., Lyden, P. D. & Saver, J. L. Disability status at 1 month is a reliable proxy for final ischemic stroke outcome. Neurology 75, 688–692 (2010).

    Article  Google Scholar 

  4. Intercollegiate Stroke Working Party. National clinical guideline for stroke [online], (2012).

  5. Thrift, A. G. et al. Discharge is a critical time to influence 10-year use of secondary prevention therapies for stroke. Stroke 45, 539–544 (2014).

    Article  Google Scholar 

  6. Park, J.-H. & Ovbiagele, B. Optimal combination secondary prevention drug treatment and stroke outcomes. Neurology 84, 50–56 (2015).

    Article  CAS  Google Scholar 

  7. McGrath, E. R., Eikelboom, J. W., Kapral, M. K. & O'Donnell, M. J., Novel oral anticoagulants: a focused review for stroke physicians. Int. J. Stroke 9, 71–78 (2014).

    Article  Google Scholar 

  8. Turner, M. et al. The impact of stroke unit care on outcome in a Scottish stroke population, taking into account case mix and selection bias. J. Neurol. Neurosurg. Psychiatry 86, 314–318 (2015).

    Article  Google Scholar 

  9. Dorman, P., Waddell, F., Slattery, J., Dennis, M. & Sandercock, P. Are proxy assessments of health status after stroke with the EuroQol questionnaire feasible, accurate and unbiased? Stroke 28, 1883–1887 (1997).

    Article  CAS  Google Scholar 

  10. Sandercock, P. et al. A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol. Assess. 6, 1–112 (2002).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Applied Medicine, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZN, UK

    Mary Joan MacLeod & Melanie Turner

Authors
  1. Mary Joan MacLeod
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Melanie Turner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mary Joan MacLeod.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

MacLeod, M., Turner, M. Stroke outcomes after 90 days—out of sight, out of mind?. Nat Rev Neurol 11, 187–188 (2015). https://doi.org/10.1038/nrneurol.2015.28

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2015.28

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing